273 related articles for article (PubMed ID: 25193361)
21. A comparison of the safety and effectiveness of dabigatran and warfarin in non-valvular atrial fibrillation patients in a large healthcare system.
Villines TC; Schnee J; Fraeman K; Siu K; Reynolds MW; Collins J; Schwartzman E
Thromb Haemost; 2015 Nov; 114(6):1290-8. PubMed ID: 26446456
[TBL] [Abstract][Full Text] [Related]
22. Cardiovascular, Bleeding, and Mortality Risks of Dabigatran in Asians With Nonvalvular Atrial Fibrillation.
Chan YH; Yen KC; See LC; Chang SH; Wu LS; Lee HF; Tu HT; Yeh YH; Kuo CT
Stroke; 2016 Feb; 47(2):441-9. PubMed ID: 26732563
[TBL] [Abstract][Full Text] [Related]
23. Comparison of outcomes after cardioversion or atrial fibrillation ablation in patients with differing periprocedural anticoagulation regimens.
Kochhäuser S; Khaykin Y; Beardsall J; Juta R; Hache P; Trought K; Lenton-Brym T; Tsang B; Pantano A; Beardsall M; Wulffhart Z; Verma A
Can J Cardiol; 2014 Dec; 30(12):1541-6. PubMed ID: 25475459
[TBL] [Abstract][Full Text] [Related]
24. Integrating real-time clinical information to provide estimates of net clinical benefit of antithrombotic therapy for patients with atrial fibrillation.
Eckman MH; Wise RE; Speer B; Sullivan M; Walker N; Lip GY; Kissela B; Flaherty ML; Kleindorfer D; Khan F; Kues J; Baker P; Ireton R; Hoskins D; Harnett BM; Aguilar C; Leonard A; Prakash R; Arduser L; Costea A
Circ Cardiovasc Qual Outcomes; 2014 Sep; 7(5):680-6. PubMed ID: 25205788
[TBL] [Abstract][Full Text] [Related]
25. Oral anticoagulants for stroke prevention in atrial fibrillation.
Senoo K; Lane DA; Lip GY
Curr Probl Cardiol; 2014 Sep; 39(9):319-44. PubMed ID: 25194766
[TBL] [Abstract][Full Text] [Related]
26. XANTUS: a real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation.
Camm AJ; Amarenco P; Haas S; Hess S; Kirchhof P; Kuhls S; van Eickels M; Turpie AG;
Eur Heart J; 2016 Apr; 37(14):1145-53. PubMed ID: 26330425
[TBL] [Abstract][Full Text] [Related]
27. Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial.
Steinberg BA; Hellkamp AS; Lokhnygina Y; Patel MR; Breithardt G; Hankey GJ; Becker RC; Singer DE; Halperin JL; Hacke W; Nessel CC; Berkowitz SD; Mahaffey KW; Fox KA; Califf RM; Piccini JP;
Eur Heart J; 2015 Feb; 36(5):288-96. PubMed ID: 25209598
[TBL] [Abstract][Full Text] [Related]
28. Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study.
Abraham NS; Singh S; Alexander GC; Heien H; Haas LR; Crown W; Shah ND
BMJ; 2015 Apr; 350():h1857. PubMed ID: 25910928
[TBL] [Abstract][Full Text] [Related]
29. Analysis of the efficacy and safety of new oral anticoagulant drugs in the secondary stroke prevention in patients with AF: single center experience based on 311 patients.
Lasek-Bal A; Urbanek T; Gierek D
Int Angiol; 2015 Dec; 34(6):552-61. PubMed ID: 25410296
[TBL] [Abstract][Full Text] [Related]
30. Consideration of clinical variables for choosing new anticoagulant alternatives to warfarin for the management of non-valvular atrial fibrillation.
Lu Y; Branstad R; Karim RM; Asinger RW
J Clin Pharm Ther; 2014 Dec; 39(6):628-36. PubMed ID: 25252149
[TBL] [Abstract][Full Text] [Related]
31. Additional events in the RE-LY trial.
Connolly SJ; Wallentin L; Yusuf S
N Engl J Med; 2014 Oct; 371(15):1464-5. PubMed ID: 25251519
[No Abstract] [Full Text] [Related]
32. Present profiles of novel anticoagulant use in Japanese patients with atrial fibrillation: insights from the Rivaroxaban Postmarketing Surveillance Registry.
Ogawa S; Ikeda T; Kitazono T; Nakagawara J; Minematsu K; Miyamoto S; Murakawa Y; Iekushi K; Yamanaka S; Yamada T; Inuyama L;
J Stroke Cerebrovasc Dis; 2014; 23(10):2520-2526. PubMed ID: 25245483
[TBL] [Abstract][Full Text] [Related]
33. Impact of non-vitamin k antagonist oral anticoagulants on intracranial bleeding in Asian patients with non-valvular atrial fibrillation.
Yasaka M; Lip GY
Circ J; 2014; 78(10):2367-72. PubMed ID: 25213003
[TBL] [Abstract][Full Text] [Related]
34. Dabigatran use in elderly patients with atrial fibrillation.
Avgil-Tsadok M; Jackevicius CA; Essebag V; Eisenberg MJ; Rahme E; Behlouli H; Pilote L
Thromb Haemost; 2016 Jan; 115(1):152-60. PubMed ID: 26354766
[TBL] [Abstract][Full Text] [Related]
35. A Comparison of Dabigatran With Warfarin for Stroke Prevention in Atrial Fibrillation in an Asian Population.
Yap LB; Eng DT; Sivalingam L; Rusani BI; Umadevan D; Muhammad Z; Koh KW; Aisha B; Hashim MI; Rebo R; Hussin A; Kaur S; Shanmugam R; Omar R
Clin Appl Thromb Hemost; 2016 Nov; 22(8):792-797. PubMed ID: 25962393
[TBL] [Abstract][Full Text] [Related]
36. Initial 3-weeks' Apixaban Versus Dual-antiplatelet Therapy (Clopidogrel and Aspirin) followed by Clopidogrel alone in high-risk patients with Acute Non-Disabling Cerebrovascular Events (ADANCE): study protocol for a randomized controlled trial.
Yang F; Lei H; Jiang W; Jiang W; Han J; Zhao G
Clin Drug Investig; 2014 Nov; 34(11):755-61. PubMed ID: 25200142
[TBL] [Abstract][Full Text] [Related]
37. Comparison of dabigatran and uninterrupted warfarin in patients with atrial fibrillation undergoing cardiac rhythm device implantations. Case-control study.
Kosiuk J; Koutalas E; Doering M; Nedios S; Sommer P; Rolf S; Darma A; Breithardt OA; Dinov B; Hindricks G; Richter S; Bollmann A
Circ J; 2014; 78(10):2402-7. PubMed ID: 25253506
[TBL] [Abstract][Full Text] [Related]
38. Rivaroxaban presents a better pharmacokinetic profile than dabigatran in an obese non-diabetic stroke patient.
Safouris A; Demulder A; Triantafyllou N; Tsivgoulis G
J Neurol Sci; 2014 Nov; 346(1-2):366-7. PubMed ID: 25240443
[No Abstract] [Full Text] [Related]
39. Antithrombotic triple therapy and coagulation activation at the site of thrombus formation: a randomized trial in healthy subjects.
Weisshaar S; Litschauer B; Gouya G; Mayer P; Smerda L; Kapiotis S; Kyrle PA; Eichinger S; Wolzt M
J Thromb Haemost; 2014 Nov; 12(11):1850-60. PubMed ID: 25211369
[TBL] [Abstract][Full Text] [Related]
40. Direct oral anticoagulants in patients with VTE and cancer: a systematic review and meta-analysis.
Vedovati MC; Germini F; Agnelli G; Becattini C
Chest; 2015 Feb; 147(2):475-483. PubMed ID: 25211264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
